Engin Eren Kavak

11PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Deep learningLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 14, 2026
CEA and CA-19-9 Dynamics Associate with Survival in Regorafenib-Treated Metastatic Colorectal Cancer: A Real-World Analysis.

Merih Yalçıner, Mehmet Berk Örüncü, Mehmet Kayaalp

|Apr 14, 2026
Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis.

Selahattin Çelik, Engin Eren Kavak, Esra Zeynelgil

|Jan 27, 2026
Prognostic Significance of Lung Immune Prognostic Index at Diagnosis in Stage III Non-Small Cell Lung Cancer.

Tülay Eren, Engin Eren Kavak, İsmail Dili

|Jan 10, 2026
Prognostic Value of STAS, Lymph Node Metastasis, and VPI in NSCLC ≤ 4 cm Treated with Lobectomy.

Esra Zeynelgil, Abdülkadir Koçanoğlu, Ata Türker Arıkök

|Dec 16, 2025
BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy.

Esra Zeynelgil, Engin Eren Kavak, İsmail Dilli

|Nov 18, 2025
Development and validation of an AI-augmented deep learning model for survival prediction in de novo metastatic colorectal cancer.

Merih Yalçıner, Efe Cem Erdat, Engin Eren Kavak

Pageof 2

Frequent Collaborators

5 joint publications

Efe Cem Erdat

4 joint publications

İsmail Dilli

4 joint publications

Esra Zeynelgil

2 joint publications

Hakan Akbulut